DHR Awarded Pediatric Asthma Certification  from the Joint Commission

Translate to Spanish or other 102 languages!

Pediatric Asthma

- Advertisement -

Mega Doctor News – 

Edinburg, TX––Doctors Hospital at Renaissance (DHR) today announced that it has earned The Joint Commission’s Gold Seal of Approval® for Pediatric Asthma Certification. The Gold Seal of Approval® is a symbol of quality that reflects an organization’s commitment to providing safe and effective patient care.

To receive this award, DHR underwent a rigorous on-site review in April 2016. Joint Commission experts evaluated compliance with national disease-specific care standards as well as with pediatric asthma-specific requirements. Clinical practice guidelines and performance measures also were assessed.

- Advertisement -

The Pediatric Asthma program at DHR was developed to engage with the community and increase public awareness about asthma management. The team of pediatric asthma specialists at DHR is dedicated to ensuring that each child can live an active and healthy lifestyle. The interdisciplinary team at DHR includes physicians, physician assistants, nurse practitioners, case managers/social workers, pharmacists, dieticians, respiratory therapists, nurses, asthma coordinators, behavioral health care providers and laboratory personnel.

Established in 2002 and awarded for a two-year period, The Joint Commission’s Disease-Specific Care Certification evaluates clinical programs across the continuum of care and addresses three core areas:

•Compliance with consensus-based national standards;

•Effective use of evidence-based clinical practice guidelines to manage and optimize care; and

- Advertisement -

•An organized approach to performance measurement and improvement activities.

“Doctors Hospital at Renaissance has thoroughly demonstrated a high level of care for pediatric patients with asthma,” said Wendi J. Roberts, RN, executive director, Certification Programs, The Joint Commission. “We commend DHR for becoming a leader in pediatric asthma care, potentially providing a higher standard of service for young asthmatic patients in its community.”

“DHR is pleased to receive Disease-Specific Care Certification from The Joint Commission, the premier health care quality improvement and accrediting body in the nation,” added Israel Rocha, DHR’s Chief Executive Officer. “The certification provides us with the framework to create a culture of excellence for those in our community.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

New FDA Nexus NAIN Targets Breakthrough Treatments for Brain and Nervous System Disorders

The U.S. Food and Drug Administration today announced the launch of the Neuroscience Advancement and Innovation Nexus (NAIN), a new agency program aligned with the Trump Administration’s efforts to accelerate medical innovation and deliver breakthrough treatments.

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

Dr. Lisa Chapa Explains Why Not Every Breast Lump Is Cancer

 Discovering a lump in the breast can cause immediate concern, but many breast abnormalities are not cancerous, according to Dr. Lisa Chapa, a breast surgeon who explained how physicians distinguish benign conditions from breast cancer.

DHR Health Expands Behavioral Health Team with Dr. Alexandra Treviño, Psychiatrist

 DHR Health, the largest provider of specialty healthcare in the Rio Grande Valley, is pleased to announce that Dr. Alexandra Treviño, has joined its team of physicians.
- Advertisement -